Lexeo Therapeutics Cash Flow Statement 2022-2025 | LXEO

Fifteen years of historical annual cash flow statements for Lexeo Therapeutics (LXEO).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022
$-98.33$-66.39$-59.28
$0.30$0.27$0.12
$14.15$5.15$2.81
$14.45$5.42$2.93
$0$0$0
$0$0$0
$2.38$-0.18$-0.43
$-3.02$-0.43$-2.24
$2.73$1.48$1.79
$-81.15$-59.50$-54.56
$-0.48$-0.12$-0.67
$0$-0.05$-0.23
$0$0$0
$0$0$0
$-93.60$0$0
$-93.60$0$0
$0$0$0
$-94.08$-0.17$-0.90
$-0.41$3.58$-0.16
$0$0$0
$-0.41$3.58$-0.16
$89.19$100$0.33
$89.19$100$0.35
$0$0$0
$0$-0.09$0
$88.78$104$0.19
$-86.45$44.13$-55.27
$12.47$3.04$1.78
$0$0$0